LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $253,000 | -1.6% | 1,658 | -38.5% | 0.00% | -50.0% |
| Q3 2020 | $257,000 | +20.7% | 2,695 | +59.3% | 0.00% | 0.0% |
| Q1 2019 | $213,000 | +2.9% | 1,692 | +10.7% | 0.00% | 0.0% |
| Q4 2018 | $207,000 | -53.8% | 1,529 | -6.4% | 0.00% | -50.0% |
| Q3 2018 | $448,000 | +41.3% | 1,633 | +6.8% | 0.00% | +33.3% |
| Q2 2018 | $317,000 | +21.5% | 1,529 | -3.2% | 0.00% | 0.0% |
| Q1 2018 | $261,000 | -56.6% | 1,579 | -73.2% | 0.00% | -72.7% |
| Q3 2016 | $601,000 | +5.1% | 5,891 | +22.9% | 0.01% | -8.3% |
| Q2 2016 | $572,000 | +84.5% | 4,794 | -18.8% | 0.01% | -7.7% |
| Q4 2013 | $310,000 | +25.5% | 5,901 | +3.4% | 0.01% | +18.2% |
| Q3 2013 | $247,000 | – | 5,707 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |